Friday, May 24, 2013 Last update: 11:03 AM
Company Tech News as it Breaks
Trade Events
Fibrocell Science, Inc.
News articles for Fibrocell Science, Inc.:
Wednesday, May 15, 2013
- Fibrocell Science Announces Approval of Common Stock Listing on NYSE MKTFibrocell Science, Inc. (OTC:FCSCD) announced today that its common stock has been approved for listing on the NYSE MKT. Trading is expected to commence on the NYSE MKT ... read more
Thursday, May 2, 2013
- Fibrocell Science Expands Potential Medical Applications for Azficel-TFibrocell Science, Inc. (OTC:FCSCD) announced today the initiation of a Phase II trial for azficel-T, an autologous fibroblast cellular product, for the treatment of restrictive burn scars (RBS). ... read more
Monday, April 29, 2013
- Fibrocell Science Announces One-for-Twenty-Five Reverse Stock Split - Fibrocell Has Been Cleared to Submit Listing Application to the NYSE MKTFibrocell Science, Inc. (OTC BB: FCSC) announced today that it will implement a one-for-twenty-five reverse stock split of its common shares effective at the opening of business on ... read more
Friday, April 26, 2013
- Fibrocell Science LAVIV® Recognized as 2013 Edison Awards’ Silver WinnerFibrocell Science, Inc. (OTC: FCSC) today announced that LAVIV® (azficel-T) was recognized as the Silver Winner in aesthetics of the science/medical category at the 2013 Edison Awards Ceremony and ... read more
Monday, April 15, 2013
- Fibrocell Science Autologous Fibroblast Injections Show Improvement in Facial Acne Scar AppearanceFibrocell Science, Inc. (OTC: FCSC) today announced that its Phase 2 study to evaluate the safety and efficacy of azficel-T (LAVIV®) for the treatment of patients with moderate-to-severe ... read more
Wednesday, March 20, 2013
- Fibrocell/UCLA Study on Human Skin Cells Yields Promising ResultsFibrocell Science, Inc.(OTC: FCSC) announced today that its research collaboration with UCLA has resulted in a discovery that may lead to a more predictable, commercially viable method of ... read more
Tuesday, March 5, 2013
- Douglas J. Swirsky Joins Fibrocell BoardFibrocell Science, Inc. (OTC: FCSC) announced today that Douglas J. Swirsky, CPA, CFA, joined its Board of Directors. Since 2006, Mr. Swirsky has served as Senior Vice President, ... read more
Thursday, February 21, 2013
- Fibrocell Adds New Member to its BoardFibrocell Science, Inc. (OTC: FCSC) announced today that Christine St.Clare, a former KPMG LLP partner, joined the Company’s Board of Directors effective February 21, 2013. She will serve ... read more
Tuesday, February 19, 2013
- CORRECTING and REPLACING Fibrocell Science Initiates New Study on Autologous CrèmePlease replace the release due to updated contact information. The corrected release reads: FIBROCELL ... read moreFibrocell Science Initiates New Study on Autologous CrèmeFibrocell Science, Inc. announced today that it has initiated a study to evaluate a new autologous skin care crème. The study, being conducted under the supervision of David ... read more
Monday, January 7, 2013
- Fibrocell Science, Inc. to Present at the 6th Annual OneMedForum San Francisco 2013Fibrocell Science, Inc., a biotechnology company at the forefront of research into the potential medical and aesthetic use of autologous fibroblasts, announced today that David Pernock, the Company’s ... read more
Monday, December 17, 2012
- Fibrocell Science, Inc. to Initiate Phase II Clinical Trial for Restrictive Burn ScarsFibrocell Science, Inc., a biotechnology company at the forefront of research into the potential medical and aesthetic use of fibroblasts, plans to initiate a Phase II clinical trial ... read more